• Profile
Close

Two prophylactic pain management regimens for medical abortion ≤ 63 days' gestation with mifepristone and misoprostol: A multicenter, randomized, placebo-controlled trial

Contraception Jan 16, 2021

Dragoman MV, Grossman D, Nguyen MH, et al. - Via performing a randomized, placebo-controlled trial in Nepal, South Africa, and Vietnam, researchers examined if in women ≤ 63 days' gestation having a mifepristone-misoprostol medical abortion, lower maximal pain is observed with providing either prophylactic tramadol 50 mg or ibuprofen 400 mg/metoclopramide 10 mg compared with placebo. A total of 563 patients were enrolled between June 2016 and October 2017. Although not clinically significant, lower mean maximum pain scores were achieved in correlation with tramadol or ibuprofen/metoclopramide co-administered with misoprostol and repeated 4 h later compared with placebo. Least likelihood to using additional analgesia was observed among women who received ibuprofen/metoclopramide along with fewer side effects.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay